Author:
Zhang Xiaoting,Liu Jinhai,Deng Xiaoming,Bo Lulong
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Due to its high infectivity, the pandemic has rapidly spread and become a global health crisis. Emerging evidence indicates that endothelial dysfunction may play a central role in the multiorgan injuries associated with COVID-19. Therefore, there is an urgent need to discover and validate novel therapeutic strategies targeting endothelial cells. PIEZO1, a mechanosensitive (MS) ion channel highly expressed in the blood vessels of various tissues, has garnered increasing attention for its potential involvement in the regulation of inflammation, thrombosis, and endothelial integrity. This review aims to provide a novel perspective on the potential role of PIEZO1 as a promising target for mitigating COVID-19-associated endothelial dysfunction.
Reference125 articles.
1. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review;Wiersinga;JAMA J Am Med Assoc,2020
2. A fatal extrapulmonary manifestation of COVID-19;Para;Chest,2020
3. New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression;Liu;J Med Virol,2022
4. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study;Katsoularis;Bmj,2022
5. Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity;Solis;Nature,2019